{"database": "openregs", "table": "documents", "rows": [["FDA-2019-D-3679-0014", "FDA", "FDA-2019-D-3679", "Interacting With the Food and Drug Administration on Complex Innovative Trial Designs for Drugs and Biological Products; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-17T05:00:00Z", 2020, 12, "2020-12-17T05:00:00Z", null, "2020-12-17T19:10:20Z", "2020-27813", 0, 0, "09000064849a443c"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2019-D-3679-0014"], "units": {}, "query_ms": 112.43024503346533, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}